Last reviewed · How we verify
Mecobalamin IV Injection
At a glance
| Generic name | Mecobalamin IV Injection |
|---|---|
| Sponsor | Eisai Co., Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo (NA)
- Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mecobalamin IV Injection CI brief — competitive landscape report
- Mecobalamin IV Injection updates RSS · CI watch RSS
- Eisai Co., Ltd. portfolio CI